个体化治疗选择使骨转移患者局部挽救治疗率降低
该研究回顾性分析了2016年至2018年间单中心1754例非脊柱骨转移患者的放疗记录,旨在评估不同放疗技术后局部挽救治疗(LST)的发生率。结论认为,在根据患者特征选择治疗模式的情况下,LST率较低,且SBRT可能降低高治疗失败风险患者的再治疗率。
要点
- 非脊柱骨转移放疗后局部挽救治疗率低,6个月累积发生率为2.5%。
- 年轻、高KPS评分和骨盆病变患者再治疗风险较高。
核心结论
- 在大规模单中心队列中,非脊柱骨转移患者局部挽救治疗率低,且不同放疗技术间无差异。
- 根据患者特征选择治疗模式时,局部挽救治疗率低于随机选择治疗的情况。
主要发现
- 所有放疗中,多次分割外照射占51.5%,单次外照射占7.0%,SBRT占41.4%。
- 88例(5.0%)需要局部挽救治疗,6个月累积发生率为2.5%。
- 年轻、KPS评分较高和骨盆病变患者再治疗风险更高。
临床怎么用
- 对于非脊柱骨转移患者,可根据患者特征个体化选择放疗技术,局部挽救治疗率较低。
- 对高治疗失败风险患者,可考虑使用SBRT以降低再治疗率。
局限性
- 回顾性单中心研究,治疗选择由医生 discretion 决定,可能存在选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Local therapy for patients with nonspine bone metastases is evolving, with data supporting the use of single-fraction treatments, and more recently, showing possible benefit from stereotactic body radiation therapy (SBRT). However, the rate of local salvage therapy (LST) after each technique has not been characterized in real-world clinic settings where patients are selected at physician discretion. We examined rates of LST in patients with nonspine bone metastases. METHODS AND MATERIALS: We reviewed records of RT for nonspine bone metastases at our institution from January 1, 2016, to December 31, 2018. We defined LST as the first occurrence of RT or surgery for oncologic progression to a bone metastasis after initial RT. Cumulative incidence functions for retreatment were generated. We conducted multivariate analysis to identify variables associated with LST. RESULTS: A total of 1754 patients were analyzed, with median follow-up of 16.2 months (range, 0-36.8 months). Of all episodes of RT, 51.5% were multifraction external beam radiation therapy (EBRT), 7.0% were single-fraction EBRT, and 41.4% were SBRT. Altogether, 88 patients (5.0%) required LST, with an incidence at 6 months of 2.5%. Incidence of LST at 6 months was 2.1% for SBRT, 5.3% for single-fraction conventional regimens, and 2.4% for multifraction conventional regimens (P = .26). Patients of younger age, who had a higher Karnofsky performance status, and/or who had lesions in the pelvis had a higher risk of retreatment. CONCLUSIONS: In this large institutional cohort, the rate of LST was low, with no difference between RT techniques. The findings indicated that SBRT for patients at high risk for treatment failure may reduce the rate of retreatment overall. When treatment modality was selected based on patient characteristics, rates of LST were lower than when treatment was randomly selected.
引用
- Mathis NJ, Doyle CJ, Rosen DB, et al. Personalized Treatment Selection Leads to Low Rates of Local Salvage Therapy for Bone Metastases. Int J Radiat Oncol Biol Phys. 2021. PMID: 34715255. doi:10.1016/j.ijrobp.2021.06.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。